| abstract |
Disclosed is a novel compound for use as an active ingredient in a preventive or therapeutic agent for a disease involving NF-κB and TNFα, which has an excellent inhibitory effect on IκB kinase and further suppresses TNFα production. The present invention relates to dihydrothieno [2,3-e] indazole compounds, pharmaceutical compositions containing them, and their use in the prevention or treatment of disease. [Selection figure] None |